The 3rd Joint Scientific Meeting EANETT/HAT Platform¹ was held in Kinshasa from 17th to 19th September.
Among a total of 250 attendees, key regional actors of MOH from HAT Platform member countries (Sudan, South Sudan, Uganda, Chad, CAR, DRC, ROC, Angola) and international NGOs (WHO, BMGF, FIND, ITM, DNDi) participated in the meeting and showed great interest in every topic during the event.
The discussed topics covered the need for combining a rapid diagnostic test and the new oral drug Fexinidazole for integrated HAT diagnosis and treatment, and generated strong consensus among participants. “We must look into the integration of all tools and what would be the best combination of interventions for local settings by considering the coverage, performance, acceptability and throughput of diagnostics,” said a program officer from the Bill and Melinda Gates Foundation during his presentation.
SD also participated in the platform to introduce the SD BIOLINE HAT rapid test and discussed with NGOs and customers the effectiveness of RDT supported by the results of evaluations conducted by FIND.
In collaboration with FIND, SD will support the HAT training program to be undertaken in DRC and other HAT endemic countries in sub-Saharan Africa.
- 1st scientific meeting held in Nairobi in October 2010
- 2nd scientific meeting held in Nairobi in June 2013
See more information on the HAT Platform: